These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21470154)

  • 1. Glycopeptide antibiotics and their novel semi-synthetic derivatives.
    Jeya M; Moon HJ; Lee KM; Kim IW; Lee JK
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1194-204. PubMed ID: 21470154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopeptide antibiotics: from conventional molecules to new derivatives.
    Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
    Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
    Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Properties, and Mechanism of Action of New Generation of Polycyclic Glycopeptide Antibiotics.
    Olsufyeva EN; Tevyashova AN
    Curr Top Med Chem; 2017; 17(19):2166-2198. PubMed ID: 28137232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN
    J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
    Olsuf'eva EN; Preobrazhenskaia MN
    Bioorg Khim; 2006; 32(4):339-59. PubMed ID: 16909859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
    Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
    Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.
    van Groesen E; Innocenti P; Martin NI
    ACS Infect Dis; 2022 Aug; 8(8):1381-1407. PubMed ID: 35895325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisynthetic glycopeptides: chemistry, structure-activity relationships and prospects.
    Ciabatti R; Malabarba A
    Farmaco; 1997 May; 52(5):313-21. PubMed ID: 9274002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in Glycopeptide Antibiotics.
    Blaskovich MAT; Hansford KA; Butler MS; Jia Z; Mark AE; Cooper MA
    ACS Infect Dis; 2018 May; 4(5):715-735. PubMed ID: 29363950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and biology of glycopeptides with antibiotic activity.
    Tan H; Guo H; Wang S; Kong Q; Li W; Zeng W
    Protein Pept Lett; 2014; 21(10):1031-47. PubMed ID: 24975667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptides: Update on an old successful antibiotic class.
    Pace JL; Yang G
    Biochem Pharmacol; 2006 Mar; 71(7):968-80. PubMed ID: 16412985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE; Somner EA
    Drugs Exp Clin Res; 1990; 16(8):385-9. PubMed ID: 2151441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies.
    Dhanda G; Sarkar P; Samaddar S; Haldar J
    J Med Chem; 2019 Apr; 62(7):3184-3205. PubMed ID: 30404451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the synthesis of new glycopeptide antibiotics.
    Ashford PA; Bew SP
    Chem Soc Rev; 2012 Feb; 41(3):957-78. PubMed ID: 21829829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycopeptide sulfation evades resistance.
    Kalan L; Perry J; Koteva K; Thaker M; Wright G
    J Bacteriol; 2013 Jan; 195(1):167-71. PubMed ID: 23104813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopeptide antibiotics: back to the future.
    Butler MS; Hansford KA; Blaskovich MA; Halai R; Cooper MA
    J Antibiot (Tokyo); 2014 Sep; 67(9):631-44. PubMed ID: 25118105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.